Translation of "Confidence interval" in German
																						The
																											limits
																											of
																											the
																											confidence
																											interval
																											around
																											the
																											vaccine
																											efficacy
																											were
																											calculated.
																		
			
				
																						Die
																											Grenzwerte
																											des
																											Konfidenzintervalls
																											zur
																											Wirksamkeit
																											des
																											Impfstoffes
																											wurden
																											berechnet.
															 
				
		 ELRC_2682 v1
			
																						The
																											rate
																											(95%
																											confidence
																											interval)
																											of
																											lymphomas
																											was
																											0.7
																											(0.2,
																											2.7)
																											per
																											1,000
																											patient-years
																											among
																											adalimumab-treated
																											patients
																											and
																											0.6
																											(0.1,
																											4.5)
																											per
																											1,000
																											patient-years
																											among
																											control
																											patients.
																		
			
				
																						Die
																											Rate
																											(95
																											%
																											Konfidenzintervall)
																											für
																											Lymphome
																											betrug
																											0,7
																											(0,2;
															 
				
		 ELRC_2682 v1
			
																						The
																											narrow
																											confidence
																											interval
																											excludes
																											any
																											clinically
																											relevant
																											beneficial
																											effects.
																		
			
				
																						Das
																											schmale
																											Konfidenzintervall
																											schließt
																											alle
																											klinisch
																											relevanten
																											positiven
																											Wirkungen
																											aus.
															 
				
		 ELRC_2682 v1
			
																						The
																											rate
																											(95
																											%
																											confidence
																											interval)
																											of
																											lymphomas
																											was
																											0.7
																											(0.2,
																											2.7)
																											per
																											1,000
																											patient-years
																											among
																											adalimumab-treated
																											patients
																											and
																											0.6
																											(0.1,
																											4.5)
																											per
																											1,000
																											patient-years
																											among
																											control
																											patients.
																		
			
				
																						Die
																											Rate
																											(95-%-Konfidenzintervall)
																											für
																											Lymphome
																											betrug
																											0,7
																											(0,2;
															 
				
		 ELRC_2682 v1
			
																						Confidence
																											interval
																											was
																											not
																											adjusted
																											for
																											multiplicity.
																		
			
				
																						Konfidenzintervall
																											wurde
																											nicht
																											für
																											Multiplizität
																											angepasst.
															 
				
		 ELRC_2682 v1
			
																						The
																											rate
																											(95%
																											confidence
																											interval)
																											of
																											non-melanoma
																											skin
																											cancers
																											was
																											8.8
																											(6.0,
																											13.0)
																											per
																											1,000
																											patient-years
																											among
																											adalimumab-treated
																											patients
																											and
																											3.2
																											(1.3,
																											7.6)
																											per
																											1,000
																											patient-years
																											among
																											control
																											patients.
																		
			
				
																						Die
																											Rate
																											(95-%-Konfidenzintervall)
																											nicht
																											melanomartiger
																											Hauttumoren
																											betrug
																											8,8
																											(6,0;
															 
				
		 ELRC_2682 v1
			
																						The
																											rate
																											(95
																											%
																											confidence
																											interval)
																											of
																											lymphomas
																											was
																											0.7
																											(0.2,
																											2.7)
																											per
																											1,000
																											patient-years
																											among
																											adalimumab-treated
																											patients
																											and
																											0.6
																											(0.1,
																											4.5)
																											per
																											1,000
																											patient-years
																											among
																		
			
				
																						Die
																											Rate
																											(95
																											%-Konfidenzintervall)
																											für
																											Lymphome
																											betrug
																											0,7
																											(0,2;
															 
				
		 ELRC_2682 v1
			
																						The
																											odds
																											ratio
																											(95%
																											exact
																											confidence
																											interval)
																											was
																											2.96
																											(1.34,
																											7.50).
																		
			
				
																						Die
																											Odds-Ratio
																											(95%
																											bestimmtes
																											Konfidenzintervall)
																											betrug
																											2,96
																											(1,34;
															 
				
		 ELRC_2682 v1
			
																						The
																											rate
																											(95
																											%
																											confidence
																											interval)
																											of
																											lymphomas
																											was
																											0.7
																											(0.2,
																											2.7)
																											per
																											1,000
																											patient
																											years
																											among
																											adalimumab-treated
																											patients
																											and
																											0.6
																											(0.1,
																											4.5)
																											per
																											1,000
																											patient
																											years
																											among
																											control
																											patients.
																		
			
				
																						Die
																											Rate
																											(95
																											%
																											Konfidenzintervall)
																											für
																											Lymphome
																											betrug
																											0,7
																											(0,2;
															 
				
		 ELRC_2682 v1
			
																						The
																											rate
																											(95%
																											confidence
																											interval)
																											of
																											lymphomas
																											was
																											0.7
																											(0.2,
																											2.7)
																											per
																											1,000
																											patient-years
																											among
																											Humira-treated
																											patients
																											and
																											0.6
																											(0.1,
																											4.5)
																											per
																											1,000
																											patient-years
																											among
																											control
																											patients.
																		
			
				
																						Die
																											Rate
																											(95
																											%
																											Konfidenzintervall)
																											für
																											Lymphome
																											betrug
																											0,7
																											(0,2;
															 
				
		 ELRC_2682 v1
			
																						The
																											odds
																											ratio
																											(95%
																											exact
																											confidence
																											interval)
																											was
																											1.21
																											(0.7,
																											2.1).
																		
			
				
																						Die
																											Odds-Ratio
																											(95
																											%
																											Konfidenzintervall)
																											betrug
																											1,21
																											(0,7;
															 
				
		 ELRC_2682 v1
			
																						The
																											upper
																											bound
																											of
																											the
																											confidence
																											interval
																											excluded
																											a
																											pre-defined
																											risk
																											margin
																											of
																											1.8.
																		
			
				
																						Die
																											obere
																											Grenze
																											des
																											Konfidenzintervalls
																											schloss
																											eine
																											vordefinierte
																											Risikomarge
																											von
																											1,8
																											aus.
															 
				
		 ELRC_2682 v1
			
																						The
																											p
																											value
																											and
																											confidence
																											interval
																											were
																											calculated
																											using
																											the
																											Wald
																											method.
																		
			
				
																						Der
																											p-Wert
																											und
																											das
																											Konfidenzintervall
																											wurden
																											nach
																											der
																											Methode
																											von
																											Wald
																											berechnet.
															 
				
		 ELRC_2682 v1
			
																						This
																											confidence
																											interval
																											will
																											then
																											equate
																											to
																											the
																											measurement
																											uncertainty
																											of
																											the
																											result.
																		
			
				
																						Dieses
																											Konfidenzintervall
																											gibt
																											dann
																											Aufschluss
																											über
																											die
																											Messunsicherheit
																											des
																											Ergebnisses.
															 
				
		 DGT v2019